These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23238465)

  • 1. Characterization of motor, depressive-like and neurochemical alterations induced by a short-term rotenone administration.
    Morais LH; Lima MM; Martynhak BJ; Santiago R; Takahashi TT; Ariza D; Barbiero JK; Andreatini R; Vital MA
    Pharmacol Rep; 2012; 64(5):1081-90. PubMed ID: 23238465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine.
    Santiago RM; Barbieiro J; Lima MM; Dombrowski PA; Andreatini R; Vital MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1104-14. PubMed ID: 20547199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin restores rotenone induced depressive-like symptoms in animal model of neurotoxicity: assessment by social interaction test and sucrose preference test.
    Madiha S; Haider S
    Metab Brain Dis; 2019 Feb; 34(1):297-308. PubMed ID: 30506334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral, neurochemical and histological alterations promoted by bilateral intranigral rotenone administration: a new approach for an old neurotoxin.
    Moreira CG; Barbiero JK; Ariza D; Dombrowski PA; Sabioni P; Bortolanza M; Da Cunha C; Vital MA; Lima MM
    Neurotox Res; 2012 Apr; 21(3):291-301. PubMed ID: 21953489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. REM sleep deprivation generates cognitive and neurochemical disruptions in the intranigral rotenone model of Parkinson's disease.
    Dos Santos AC; Castro MA; Jose EA; Delattre AM; Dombrowski PA; Da Cunha C; Ferraz AC; Lima MM
    J Neurosci Res; 2013 Nov; 91(11):1508-16. PubMed ID: 23908011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pioglitazone and retinoic acid in a rotenone model of Parkinson's disease.
    Ulusoy GK; Celik T; Kayir H; Gürsoy M; Isik AT; Uzbay TI
    Brain Res Bull; 2011 Jul; 85(6):380-4. PubMed ID: 21600965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of gait dynamics in rotenone-induced rat model of Parkinson's disease by footprint method.
    Madiha S; Tabassum S; Batool Z; Liaquat L; Sadir S; Shahzad S; Perveen T; Haider S
    Pak J Pharm Sci; 2017 May; 30(3(Suppl.)):943-948. PubMed ID: 28655689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quercetin exhibits potent antioxidant activity, restores motor and non-motor deficits induced by rotenone toxicity.
    Madiha S; Batool Z; Tabassum S; Liaquat L; Sadir S; Shahzad S; Naqvi F; Saleem S; Yousuf S; Nawaz A; Ahmad S; Sajid I; Afzal A; Haider S
    PLoS One; 2021; 16(11):e0258928. PubMed ID: 34767546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withdrawal from repeated administration of a low dose of reserpine induced opposing adaptive changes in the noradrenaline and serotonin system function: a behavioral and neurochemical ex vivo and in vivo studies in the rat.
    Antkiewicz-Michaluk L; Wąsik A; Możdżeń E; Romańska I; Michaluk J
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Mar; 57():146-54. PubMed ID: 25445479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective and antidepressant-like effects of melatonin in a rotenone-induced Parkinson's disease model in rats.
    Bassani TB; Gradowski RW; Zaminelli T; Barbiero JK; Santiago RM; Boschen SL; da Cunha C; Lima MM; Andreatini R; Vital MA
    Brain Res; 2014 Dec; 1593():95-105. PubMed ID: 25301688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term atrazine exposure causes behavioral deficits and disrupts monoaminergic systems in male C57BL/6 mice.
    Lin Z; Dodd CA; Filipov NM
    Neurotoxicol Teratol; 2013; 39():26-35. PubMed ID: 23770127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of depressive-like behavior by intranigral 6-OHDA is directly correlated with deficits in striatal dopamine and hippocampal serotonin.
    Santiago RM; Barbiero J; Gradowski RW; Bochen S; Lima MM; Da Cunha C; Andreatini R; Vital MA
    Behav Brain Res; 2014 Feb; 259():70-7. PubMed ID: 24183944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exendin-4 reverses biochemical and behavioral deficits in a pre-motor rodent model of Parkinson's disease with combined noradrenergic and serotonergic lesions.
    Rampersaud N; Harkavyi A; Giordano G; Lever R; Whitton J; Whitton PS
    Neuropeptides; 2012 Oct; 46(5):183-93. PubMed ID: 22921965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium butyrate improves locomotor impairment and early mortality in a rotenone-induced Drosophila model of Parkinson's disease.
    St Laurent R; O'Brien LM; Ahmad ST
    Neuroscience; 2013 Aug; 246():382-90. PubMed ID: 23623990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective and Therapeutic Effect of Caffeine on the Rat Model of Parkinson's Disease Induced by Rotenone.
    Khadrawy YA; Salem AM; El-Shamy KA; Ahmed EK; Fadl NN; Hosny EN
    J Diet Suppl; 2017 Sep; 14(5):553-572. PubMed ID: 28301304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of glutamate and alpha2-noradrenergic receptor antagonists on the development of neurotoxicity produced by chronic rotenone in rats.
    Alam M; Danysz W; Schmidt WJ; Dekundy A
    Toxicol Appl Pharmacol; 2009 Oct; 240(2):198-207. PubMed ID: 19616571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reboxetine attenuates forced swim test-induced behavioural and neurochemical alterations in the rat.
    Connor TJ; Kelliher P; Harkin A; Kelly JP; Leonard BE
    Eur J Pharmacol; 1999 Aug; 379(2-3):125-33. PubMed ID: 10497898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depressive-like neurochemical and behavioral markers of Parkinson's disease after 6-OHDA administered unilaterally to the rat medial forebrain bundle.
    Kamińska K; Lenda T; Konieczny J; Czarnecka A; Lorenc-Koci E
    Pharmacol Rep; 2017 Oct; 69(5):985-994. PubMed ID: 28843848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Putative role of monoamines in the antidepressant-like mechanism induced by striatal MT2 blockade.
    Noseda AC; Rodrigues LS; Targa AD; Aurich MF; Vital MA; Da Cunha C; Lima MM
    Behav Brain Res; 2014 Dec; 275():136-45. PubMed ID: 25218873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.